Blushield Clinical Study

A recent groundbreaking pilot study has been conducted on Blushield EMF Protection devices to assess the feasibility and preliminary signs of efficacy on a small sample group within a fairly short time frame, to determine if a full-scale research project would be worth planning in the future.

A variety of health markers were tested, using several methods. These included laboratory panels assessing overall physiological health; a panel of blood markers related to inflammation, oxidative stress, DNA damage and cellular senescence; a genome-wide assessment of DNA methylation (including the voltage-gated calcium channel sites); a full neurocognitive assessment every 4 weeks of the study; the use of a wearable health tracker (the Oura Ring) to analyze changes in sleep quality, heart rate variability, and related health markers; and self-reported health questionnaires.

The study paper concludes that Blushield devices appear to be feasible, safe, and associated with improvements in cognitive function, sleep, heart rate variability, voltage-gated ion channel gene normalization, blood glucose, immune response, and overall self-reported health among relatively healthy adults. It also emphasizes that the devices "appear to be a reasonable component of a comprehensive EMF mitigation strategy to minimize RF exposure".

Read the full study here | Discover Blushield EMF Protection | Blushield Product Guide